An investigational drug developed by Eolo Pharma is showing promise in animal experiments and an early human trial. It could ...

Uncover the psychophysiological roots of obesity in India to revolutionize interventions and combat the epidemic effectively.

Protagonist is directly going up against Eli Lilly, which is advancing retatrutide, also a triple-G agonist, in a Phase II ...

Obesity is a serious disease that affects more than one third of adults and over 20% of children in the USA and produces major increases in morbidity and mortality. 1, 2 There are multiple ...

An ancient ambush of wild horses at a German archaeological site called Schöningen around 300,000 years ago suggests that communal hunting, along with complex ...

MIRA Pharmaceuticals, Inc. (NASDAQ:MIRA) on Monday revealed new animal study results from SKNY-1, a next-generation oral ...

Obesity remains one of the greatest health challenges worldwide, leading to diabetes, heart disease, and increased healthcare ...

Texas Tech University (TTU) researchers’ rigorous analysis of available data challenged the longstanding public health assumptions about the risks of eating unprocessed beef.

New data from a Phase 3 trial show that the daily anti-obesity pill may be as safe and effective as drugs like Mounjaro and ...

A novel oral peptide PN-477o with once-daily dosing, high potency and activation of glucagon-like peptide-1 (GLP-1), ...

Novo Nordisk (NVO) and Eli Lilly & Co. (LLY), the global leaders in obesity medications, are now facing their first major ...